Virtu Financial’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$175K	Buy	+11,951	New	+$191K	0.01%	1053
2025 Q1	–	Sell	-16,038	Closed	-$86K	–	1474
2024 Q4	$86K	Buy	16,038 +344	+2%	+$2.57K	﹤0.01%	1052
2024 Q3	$83K	Buy	+15,694	New	+$56.4K	﹤0.01%	936
2024 Q2	–	Sell	-12,570	Closed	-$22K	–	1403
2024 Q1	$22K	Buy	+12,570	New	+$26.3K	﹤0.01%	1153
2023 Q4	–	Sell	-17,366	Closed	-$25K	–	1635
2023 Q3	$25K	Sell	17,366 -8,176	-32%	-$17.3K	﹤0.01%	978
2023 Q2	$58K	Buy	25,542 +6,188	+32%	+$12.9K	﹤0.01%	1124
2023 Q1	$18K	Buy	19,354 +596	+3%	+$465	﹤0.01%	1260
2022 Q4	$16K	Buy	+18,758	New	+$16.6K	﹤0.01%	1302
2022 Q2	–	Sell	-14,269	Closed	-$23K	–	1657
2022 Q1	$23K	Buy	+14,269	New	+$26.1K	﹤0.01%	1274
2021 Q4	–	Sell	-19,688	Closed	-$95K	–	1791
2021 Q3	$95K	Buy	+19,688	New	+$58.3K	0.01%	1158
2017 Q4	–	Sell	-10,205	Closed	-$163K	–	2435
2017 Q3	$163K	Buy	+10,205	New	+$141K	0.01%	1934